Christopher Cabell

Christopher Cabell

Director/Board Member bij PULMATRIX, INC.

Vermogen: 416 494 $ op 31-03-2024

54 jaar
Health Technology
Consumer Services
Commercial Services

Profiel

Christopher H.
Cabell
is currently the Director at ScienceMedia, Inc., Independent Director at Pulmatrix, Inc., and a Member of the American College of Cardiology Foundation.
He previously worked as the Co-Chairman at the US Food & Drug Administration and the Cardiac Safety Research Consortium.
He was also the Director-Echocardiography Core Lab at Duke Clinical Research Institute, Director at Cenduit LLC, and Senior Vice President-Global Access at Quintiles Transnational Corp.
He served as the Chief Medical & Scientific Officer at IQVIA, Inc. and IQVIA RDS, Inc. He was the Chief Medical Officer, Head-Research & Development at Arena Pharmaceuticals, Inc. and is currently the Chief Medical Officer & Head-Clinical Development at Emergent BioSolutions, Inc. He was also an Associate Professor at Duke University School of Medicine.
He holds a graduate degree from Duke University and a doctorate from Duke University School of Medicine.
He also has an undergraduate degree from The Pennsylvania State University.
He will be the Chief Medical Officer & Executive Vice President at Zura Bio Ltd.
from 2023 to 2024.

Bekende belangen in openbare bedrijven

OndernemingDatumAantal aandelenTotale waardeWaarderingsdatum
18-05-2023 162 060 ( 0.37% ) 416 494 $ 31-03-2024
25-03-2024 0 ( -.--% ) - $ 31-03-2024

Actieve functies van Christopher Cabell

BedrijvenFunctieBegin
PULMATRIX, INC. Director/Board Member 23-06-2020
Director/Board Member 18-02-2020
Corporate Officer/Principal 30-04-2009
Alle actieve functies van Christopher Cabell

Eerdere bekende functies van Christopher Cabell

BedrijvenFunctieEinde
ZURA BIO LIMITED Chief Tech/Sci/R&D Officer 15-01-2024
EMERGENT BIOSOLUTIONS INC. Chief Tech/Sci/R&D Officer 01-01-2023
ARENA PHARMACEUTICALS Chief Tech/Sci/R&D Officer 01-12-2020
Chief Tech/Sci/R&D Officer 01-09-2017
Duke University School of Medicine Corporate Officer/Principal -
Ervaring van Christopher Cabell in detail bekijken

Opleiding van Christopher Cabell

Duke University Graduate Degree
The Pennsylvania State University Undergraduate Degree
Duke University School of Medicine Doctorate Degree

Ervaring
Beklede functies

Actief

Inactief

Beursgenoteerde bedrijven

Bedrijven in privébezit

Ervaring van Christopher Cabell in detail bekijken

Connecties

100 +

Eerstegraads connecties

16

Bedrijven verbonden in de eerste graad

Man

Vrouw

Besturend

Uitvoerend

Persoonlijk netwerk weergeven

Verwante bedrijven

Beursgenoteerde bedrijven3
EMERGENT BIOSOLUTIONS INC.

Health Technology

PULMATRIX, INC.

Health Technology

ZURA BIO LIMITED

Health Technology

Bedrijven in privébezit10

Commercial Services

Technology Services

Health Technology

Health Technology

Government

Health Services

Commercial Services

Technology Services

Distribution Services

Cardiac Safety Research Consortium

Zie bedrijfsconnecties
  1. Beurs
  2. Insiders
  3. Christopher Cabell